Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$196.12
+0.6%
$177.26
$163.33
$251.99
$55.88B0.23.02 million shs2.67 million shs
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$148.14
+1.3%
$159.80
$105.01
$168.44
$34.92B0.672.17 million shs3.48 million shs
McKesson Corporation stock logo
MCK
McKesson
$662.79
+0.6%
$711.09
$464.42
$737.89
$81.97B0.5859,991 shs627,339 shs
Straumann Holding AG stock logo
SAUHY
Straumann
$11.84
-7.9%
$12.99
$10.30
$16.90
$20.51B1.52173,436 shs135,452 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
+0.65%+13.69%+10.70%+13.99%-17.00%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+1.11%-5.51%-8.38%-2.35%+44.41%
McKesson Corporation stock logo
MCK
McKesson
+0.61%-5.97%-7.49%-6.09%+20.13%
Straumann Holding AG stock logo
SAUHY
Straumann
-7.93%-6.03%-10.24%-11.84%-7.79%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
4.661 of 5 stars
2.23.04.24.03.92.51.3
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.8823 of 5 stars
3.43.04.23.62.01.72.5
McKesson Corporation stock logo
MCK
McKesson
4.7021 of 5 stars
1.45.03.33.03.92.52.5
Straumann Holding AG stock logo
SAUHY
Straumann
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
2.36
Hold$211.447.82% Upside
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.80
Moderate Buy$163.2010.17% Upside
McKesson Corporation stock logo
MCK
McKesson
2.86
Moderate Buy$719.278.52% Upside
Straumann Holding AG stock logo
SAUHY
Straumann
4.00
Strong BuyN/AN/A

Current Analyst Ratings Breakdown

Latest SAUHY, MCK, BDX, and CAH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/13/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$183.00 ➝ $185.00
8/13/2025
McKesson Corporation stock logo
MCK
McKesson
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$766.00 ➝ $772.00
8/13/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$200.00 ➝ $190.00
8/13/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$197.00 ➝ $203.00
8/12/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$150.00
8/12/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
8/12/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
8/12/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperform ➝ Outperform$188.00 ➝ $186.00
8/11/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$196.00 ➝ $197.00
8/8/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$172.00 ➝ $184.00
8/8/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$185.00 ➝ $200.00
(Data available from 8/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$20.18B2.79$21.27 per share9.22$88.87 per share2.21
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$222.58B0.16$11.81 per share12.54($11.04) per share-13.42
McKesson Corporation stock logo
MCK
McKesson
$359.05B0.23$39.08 per share16.96($12.77) per share-51.90
Straumann Holding AG stock logo
SAUHY
Straumann
$2.84B6.64$0.42 per share27.91$1.46 per share8.11
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.71B$5.5635.2712.541.467.51%16.23%7.46%N/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$852M$6.4122.9716.551.440.70%-74.45%4.14%10/31/2025 (Estimated)
McKesson Corporation stock logo
MCK
McKesson
$3.30B$25.0826.4318.091.310.84%-196.66%5.66%N/A
Straumann Holding AG stock logo
SAUHY
Straumann
$441.09MN/A0.0026.312.13N/AN/AN/AN/A

Latest SAUHY, MCK, BDX, and CAH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q4 2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.03$2.08+$0.05$1.00$60.91 billion$60.16 billion
8/7/2025Q3 2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.40$3.68+$0.28$1.99$5.50 billion$5.51 billion
8/6/2025Q1 2026
McKesson Corporation stock logo
MCK
McKesson
$8.33$8.26-$0.07$6.25$95.93 billion$97.83 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$4.162.12%N/A74.82%53 Years
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.041.38%N/A31.83%29 Years
McKesson Corporation stock logo
MCK
McKesson
$2.840.43%N/A11.32%17 Years
Straumann Holding AG stock logo
SAUHY
Straumann
$0.030.25%N/AN/AN/A

Latest SAUHY, MCK, BDX, and CAH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/30/2025
McKesson Corporation stock logo
MCK
McKesson
quarterly$0.820.46%9/2/20259/2/202510/1/2025
7/22/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$1.042.29%9/8/20259/8/20259/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.69
1.10
0.62
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.94
0.50
McKesson Corporation stock logo
MCK
McKesson
N/A
0.88
0.49
Straumann Holding AG stock logo
SAUHY
Straumann
N/A
1.61
1.15

Institutional Ownership

CompanyInstitutional Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
86.97%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
McKesson Corporation stock logo
MCK
McKesson
85.07%
Straumann Holding AG stock logo
SAUHY
Straumann
N/A

Insider Ownership

CompanyInsider Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.36%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.09%
McKesson Corporation stock logo
MCK
McKesson
0.08%
Straumann Holding AG stock logo
SAUHY
Straumann
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
74,000286.63 million285.60 millionOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
48,900238.68 million238.46 millionOptionable
McKesson Corporation stock logo
MCK
McKesson
45,000124.38 million124.28 millionOptionable
Straumann Holding AG stock logo
SAUHY
Straumann
11,8151.59 billionN/ANot Optionable

Recent News About These Companies

Straumann Holding AG (SAUHF) Q2 2025 Earnings Call Transcript
Straumann Holding AG (SAUHY) - Yahoo Finance
Straumann Holding: I'm Still A 'Hold' Based On Valuation
Straumann Holding AG (SAUHY)
Straumann Holding AG ADR (SAUHY)
Straumann price target raised by CHF 38 at UBS
Straumann Holding AG ADR
Straumann Holding AG (STMN)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Becton, Dickinson and Company stock logo

Becton, Dickinson and Company NYSE:BDX

$196.12 +1.16 (+0.59%)
Closing price 08/13/2025 03:59 PM Eastern
Extended Trading
$195.40 -0.72 (-0.37%)
As of 08/13/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Cardinal Health stock logo

Cardinal Health NYSE:CAH

$148.14 +1.84 (+1.26%)
Closing price 08/13/2025 03:59 PM Eastern
Extended Trading
$148.22 +0.08 (+0.05%)
As of 08/13/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

McKesson stock logo

McKesson NYSE:MCK

$662.79 +3.78 (+0.57%)
Closing price 08/13/2025 03:59 PM Eastern
Extended Trading
$663.30 +0.51 (+0.08%)
As of 08/13/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Straumann stock logo

Straumann OTCMKTS:SAUHY

$11.84 -1.02 (-7.93%)
As of 08/13/2025 03:58 PM Eastern

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.